A back-to-back publication showed that loss of RB1 and TP53 genes conferred the PCa lineage plasticity, metastasis, and enzalutamide resistance by developing a genetically engineered mouse model crossed with a Pten knockout mouse (78). This evidence concerns the gene RB1 and posterior cortical atrophy.